• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71992-01
Device Problem Device Alarm System (1012)
Patient Problems Hyperglycemia (1905); Pain (1994); Cramp(s) /Muscle Spasm(s) (4521)
Event Date 04/19/2021
Event Type  Injury  
Manufacturer Narrative
At this time product has not yet been returned.An extended investigation has been performed for the reported complaint and it has been determined that there was no indication that the product did not meet specification.The dhrs (device history review) for the libre sensor and libre sensor kit were reviewed and the dhrs showed the libre sensor and libre sensor kit passed all tests prior to release.If the product is returned, a physical investigation will be performed and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
An alarm issue was reported with the freestyle libre 2 sensor.Customer reported the high glucose alarm did not sound and because of this, he experienced symptoms described as blurred sight, loss of strength, body pain and cramping.Customer was unable to self-treat and required treatment of rapid insulin by a third-party.There was no report of death or permanent injury associated with this event.
 
Manufacturer Narrative
Sensor (b)(6) has been returned and investigated.A visual inspection was performed on the returned sensor patch and no issues were observed.Extracted data from the returned sensor using approved software.Sensor found to be in state 5 (indicating normal termination).The sensor plug was properly seated, and no failure modes observed on the sensor plug assembly during visual inspection.The sensor was activated with a known good reader to perform linearity test and the linearity test successfully activated high glucose alarms.No malfunction or product deficiency was identified.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
An alarm issue was reported with the freestyle libre 2 sensor.Customer reported the high glucose alarm did not sound and because of this, he experienced symptoms described as blurred sight, loss of strength, body pain and cramping.Customer was unable to self-treat and required treatment of rapid insulin by a third-party.There was no report of death or permanent injury associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 2
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
MDR Report Key11735827
MDR Text Key247661040
Report Number2954323-2021-67595
Device Sequence Number1
Product Code QLG
Combination Product (y/n)N
PMA/PMN Number
K193371
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 09/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/28/2022
Device Model Number71992-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/11/2021
Initial Date Manufacturer Received 04/22/2021
Initial Date FDA Received04/27/2021
Supplement Dates Manufacturer Received08/27/2021
Supplement Dates FDA Received09/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
Patient Weight70
-
-